安慰依达拉奉治疗急性青年脑梗塞50例疗效分析.docVIP

安慰依达拉奉治疗急性青年脑梗塞50例疗效分析 　　摘要：目的 分析依达拉奉治疗急性脑梗塞的临床效果。方法 本院将收治的急性青年脑梗塞患者50例，随机分为观察组和对照组，两组均行常规脱水、抗血小板等治疗，观察组在此基础上辅以30毫克依达拉奉进行治疗，比较两组患者的临床疗效。结果 治疗后，观察组25例患者，5例痊愈，11例显著进步，6例进步，3例无效，治疗有效率为88%。对照组25例患者，3例痊愈，6例显著进步，7例进步，9例无效，治疗有效率为64%，差异具有统计学意义（P0.05）。结论 采用依达拉奉辅助治疗急性青年脑梗塞具有较好的临床疗效，不仅能够缓解患者的临床症状，还能降低患者出现并发症的几率，值得临床推广使用。 　　 　　Comfort with dara in treatment of acute youth cerebral infarction curative effect analysis of 50 cases 　　ChenJianjunMeiZhizhongYuYingliFangHaowei 　　Dongguan Houjie hospital Brain surgery Guangdong Dongguan 523945 　　Abstract：Objective Analyze the clinical effect of edaravone in treatment of acute cerebral infarction. Method The 50 cases of patients with acute cerebral infarction in young admitted, were randomly divided into observation group and control group, two groups were treated with conventional dehydration, antiplatelet therapy, based on the observation group supplemented with 30 mg edaravone treatment, the clinical efficacy of two groups were compared. Result After treatment, the observation group of 25 cases, 5 cases were cured, 11 cases of significant progress, progress in 6 cases, 3 cases were invalid, the effective rate of treatment was 88%. The control group of 25 cases, 3 cases were cured, 6 cases of significant progress, progress in 7 cases, 9 cases were invalid, the effective rate of treatment was 64%, the difference was statistically significant (P0.05). Conclusion The use of edaravone auxiliary has good clinical efficacy in treatment of acute cerebral infarction in youth, can not only relieve the clinical symptoms of the patients, but also reduce the risk of complications, worthy of clinical use. 　　关键词：依达拉奉；急性脑梗塞；青年患者；临床疗效 　　 　　临床研究表明，依达拉奉是一种自由基清除剂，可抑制神经组织内的自由基生长，采用依达拉奉治疗急性青年脑梗塞患者，可提高患者的生存几率。为研究采用依达拉奉临床治疗意义，笔者对医院近两年来收治的50例急性青年脑梗塞患者的临床资料进行综合分析，观察期临床疗效，得出如下报告。 　　 　　1 资料与方法 　　1.1 一般资料 　　本组抽取我院于2011年5月至2013年5月收治的急性青年脑梗塞患者50例，将患者随机分为两组，其中观察组25例患者，男性11例，女性14例，年龄为19岁至43岁，平均年龄为（32.19±2.41）岁。经临床诊断，患者均为急性脑梗塞。本组25例患者，其中8例动脉病变，10例心源性栓塞，